A new study details the development of a nanoparticle-based system that delivers concentrated chemotherapy specifically to ...

The acquisition will expand AbbVie's exploration of in vivo CAR-T therapy, an ambitious approach that could sidestep some of ...

A new nanoparticle capable of carrying much higher doses of drugs while staying stable for extended periods could make ...

ACROBiosystems has developed a series of specialized proteases for the screening and validation of ADC linkers, focusing on ...

There's a long way to go when it comes to sex and gender equity in medicine, but engineers at The University of New Mexico hope to close the gap with ...

The immune system is central to identifying and eliminating foreign pathogens that enter the body. The innate and adaptive immune responses work together t | Immunology ...

A Nigerian biomedical researcher, Ibrahim Oladele, is developing an innovative drug delivery system that could significantly ...

SLNs are a type of nanocarrier used in drug delivery and vaccine development. They are composed of stabilized lipids and can ...

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing ...

AbbVie’s $2.1 billion acquisition of Capstan Therapeutics aims to advance in vivo CAR-T therapies, transforming autoimmune ...

U.S. drugmaker AbbVie said on Monday it will acquire cell therapy developer Capstan Therapeutics in a cash deal worth up to ...

First line of defense When healthy, the immune system is the body's first line of defense against diseases such as cancer and infections ... currently being studied, the nanoparticles are designed to ...